Chinese, Overweight or Obesity, Real-World Registry Study
NCT07525037 · Not yet recruiting
Last updated 2026-05-28This study is examining how overweight and obese adults in China with type 2 diabetes are currently being treated in real-world settings.
What this study is testing ClinicalTrials.gov NCT07525037 ↗
Description as written by the study sponsor.
This study will enroll 10,000 patients with obesity, with the participation of approximately 50 medical institutions nationwide. At baseline, demographic data, physical examinations, multiple laboratory tests (including complete blood count, urinalysis, liver/renal function, electrolytes, thyroid function panel \[3 items\], urine albumin/creatinine ratio, fasting glucose, fasting C-peptide, fasting insulin, HbA1c, blood lipids, etc.) and hepatic elasticity ultrasound will be performed. Patients will receive weight-loss therapy in routine clinical practice. Data on clinic visits, adverse events, and changes in therapeutic regimens will be centrally collected by investigators or their authorized representatives at Week 26 and Week 52.
| Main thing measured | The treatment model for overweight and obese individuals in China at present. |
|---|---|
| Sponsor | Chinese PLA General Hospital |
| Conditions studied | Obesity Type 2 Diabetes Mellitus |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07525037 ↗